ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis"

  • Abstract Number: 1955 • ACR Convergence 2024

    Ultrasound for Screening of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review and Meta Analysis

    Ikwinder Preet Kaur1, Karishma Ramsubeik2, Thway Myant3, Luis Sanchez-Ramos4, Laurie Ramrattan5 and Gurjit Kaeley6, 1University of Florida College of Medicine, Jacksonville, FL, 2Baptist Health, Jax, FL, 3UF Jacksonville, Mia, FL, 4University of Florida college of Medicine, Jacksonville, 5University of Florida, Jacksonville, FL, 6UF COM-J, Ponte Vedra Beach, FL

    Background/Purpose: Clinically significant Interstitial Lung Disease (ILD) can occur in up to 10 percent of  Rheumatoid Arthritis (RA) patients, which is associated with considerable morbidity…
  • Abstract Number: 2168 • ACR Convergence 2024

    Two Year Data on Quality of Life, Pain and Mobility Scores After Rituximab Treatment in the Preclinical Phase of Rheumatoid Arthritis

    Giulia Frazzei1, Sophie Cramer1, Robert Landewé2, Karen Maijer3, Danielle Gerlag4, Paul Tak, MD PhD5, Niek De Vries6, Lisa van Baarsen6, Ronald Van Vollenhoven7 and Sander Tas8, 1Amsterdam University Medical Center, location AMC, Amsterdam, Netherlands, 2Amsterdam University Medical Center, Meerssen, Netherlands, 3Tergooi Hospital, Hilversum, Amsterdam, Netherlands, 4UCB, Cambridge, United Kingdom, 5Candel Therapeutics, Cambridge, United Kingdom, 6Amsterdam UMC, Amsterdam, Netherlands, 7Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers, Amsterdam, Netherlands, 8Amsterdam UMC, locatie AMC, Amsterdam, Netherlands

    Background/Purpose: Over the past 10 years, several trials have investigated prevention of rheumatoid arthritis (RA) by disease modifying antirheumatic drug (DMARD) therapies. Early treatment of…
  • Abstract Number: 2225 • ACR Convergence 2024

    Role of Fatigue in Difficult to Treat Rheumatoid Arthritis

    Maria Rodriguez-Laguna1, Leticia Leon2, Dalifer Freites Nuñez3, Cristina Hormigos-martin4, jose otazu Moudelle4, Alfredo Madrid García5, Benjamin fernandez-Gutierrez2 and lydia Abasolo Alcazar6, 1Resident in Rheumatology, Madrid, Spain, 2Hospital Clinico San Carlos, Madrid, Spain, 3Hospital Clínico San Carlos. Madrid. Spain., Madrid, Spain, 4Hospital Clínico San Carlos, madrid, Spain, 5Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IDISCC), Madrid, Madrid, Spain, 6IdISSC. HCSC, Madrid, Spain

    Background/Purpose: A subset of patients with rheumatoid arthritis (RA) who remains symptomatic after failing to multiple therapies are deemed to have "difficult-to-treat" (D2T RA). Fatigue…
  • Abstract Number: 2241 • ACR Convergence 2024

    Associations Between Disease Activity, Physical Function and Anti-rheumatic Medications with All-cause Mortality in Rheumatoid Arthritis (RA): Data from a Canadian RA Registry

    Mohammad Movahedi1, Angela Cesta2, Xiuying Li2, Bindee Kuriya3, Sibel Aydin4, Ed Keystone5, Janet Pope6 and Claire Bombardier7, and OBRI investigators, 1Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 2UHN, Toronto, ON, Canada, 3University of Toronto - Toronto, Toronto, ON, Canada, 4Ottawa Hospital Research Institute, Ottawa, ON, Canada, 5Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 6University of Western Ontario, London, ON, Canada, 7University of Toronto, Toronto, ON, Canada

    Background/Purpose: Patients with rheumatoid arthritis (RA) are at increased risk of hospitalizations and mortality due to RA itself, associated comorbidities, and treatment-related complications. The purpose…
  • Abstract Number: 2261 • ACR Convergence 2024

    Risk of Cervical Intraepithelial Neoplasia During Janus Kinase (JAK) Inhibitor Treatment in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study

    Mi-Ra Cho1, Young-Eun Kim2, Yeo-Jin Lee3, Soo Min Ahn2, Seokchan Hong1, Ji Seon Oh1, Chang-Keun Lee1, Bin Yoo1 and Yong-Gil Kim1, 1Asan Medical Center, Seoul, Republic of Korea, 2Asan medical center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 3Asan medical center, Seoul, South Korea

    Background/Purpose: Janus kinase (JAK) inhibitors are increasingly used in the treatment of Rheumatoid arthritis (RA); however, concerns have been raised about their potential to elevate…
  • Abstract Number: 2279 • ACR Convergence 2024

    Discontinuation Pattern of Glucocorticoids in Patients with Rheumatoid Arthritis Initiating Biologics or Targeted Synthetic DMARDs in Routine Care

    Isabel Castrejon1, Lucia Otero-Varela2, José María Álvaro-Gracia3, Jerusalem Calvo Gutierrez4, Cristina Campos-Fernández5, Alicia García Dorta6, Ana Perez7, DOLORES RUIZ MONTESINO8 and Fernando Sánchez-Alonso9, and on behalf of BIOBADASER, 1Hospital General Universitario Gregorio Marañon, Madrid, Spain, 2Spanish Society of Rheumatology, Madrid, Spain, 3Hospital Gregorio Marañón, Madrid, Spain, 4HU Reina Sofia, Cordoba, Spain, 5Consorci Hospital General Universitari de València, Comunitat Valenciana, Spain, Valencia, Spain, 6Rheumatologist, La Laguna, Spain, 7Hospital Universitario Principe de Asturias, Alcala de Henares, Madrid, Spain, 8Hospital Virgen Macarena, Sevilla, Spain, 9Sociedad Española de Reumatología, Madrid, Spain

    Background/Purpose: Glucocorticoids (GC) have a rapid effect on symptoms, but chronic exposure is associated to important adverse events. Although both EULAR and ACR guidelines (1,2),…
  • Abstract Number: 2542 • ACR Convergence 2024

    Group 2 Innate Lymphoid Cells Aggravates Development of Inflammatory Arthritis

    Anders Nguyen1, Miriam Bollmann1, Agnieszka Lastowska2, Anna-Karin Hultgård Ekwall1, Dietmar Zaiss3, Gary Firestein4 and Mattias Svensson5, 1University of Gothenburg, Göteborg, Sweden, 2University of Gothenburg, Goteborg, Sweden, 3University Hospital Regensburg, Regensburg, Germany, 4University of California, San Diego, San Diego, CA, 5University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: Activation of fibroblast-like synoviocytes (FLS) by immune cells drives inflammation and joint damage in rheumatoid arthritis (RA). Hence, understanding factors that induce destructive behaviors…
  • Abstract Number: 2671 • ACR Convergence 2024

    Subcutaneous Abatacept vs Adalimumab Head-to-Head Comparison in Adults with Early, Dual Seropositive Rheumatoid Arthritis, Positive for the Shared Epitope HLA Class II Risk Alleles, and an Inadequate Response to Methotrexate: Results from a Phase 3 Trial

    Michael Weinblatt1, Paul Emery2, Vivian Bykerk3, Andrew Cope4, Gerd Burmester5, Yoshiya Tanaka6, Gustavo Citera7, Peter Nash8, Quentin Dornic9, Sheila Kelly10 and Michael Maldonado9, 1Brigham and Women's Hospital/ Harvard Medical School, Waban, MA, 2University of Leeds, Leeds, United Kingdom, 3Hospital For Special Surgery, New York, NY, 4King's College London, London, United Kingdom, 5Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 6Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan, 7Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 8Griffith University, Brisbane, Australia, 9Bristol Myers Squibb, Princeton, NJ, 10Bristol Myers Squibb, Doylestown, PA

    Background/Purpose: For patients (pts) early in their RA disease course, with a clinical profile characterized by inadequate response to MTX (MTX-IR), high titers of ACPA…
  • Abstract Number: 0043 • ACR Convergence 2024

    Inflammatory and Angiogenic Serum Profile of Refractory Rheumatoid Arthritis

    Manon Lesturgie-Talarek1, Virginie Gonzalez2, ALICE COMBIER3, Marion THOMAS4, Margaux Boisson5, Sandrine Carves3, Sarah Wanono3, Lucie Poiroux3, Anne Cauvet1, Sophie Hecquet6, Yannick Allanore7 and Jérôme Avouac8, 1Université de Paris, Institut Cochin, INSERM U1016 CNRS UMR8104, Paris, France, 2Université de Paris, Institut Cochin, INSERM U1016 CNRS UMR8104, Paris, Ile-de-France, France, 3Hôpital Cochin - Université Paris Cité, Paris, France, 4APHP, Paris, France, 5Hôpital Cochin - Université Paris Cité, Paris, 6Cochin Hospital, Paris, France, 7Université Paris Cité, Paris, France, 8Rheumatology A Department, Hôpital Cochin, AP-HP Centre - Université Paris Cité, Paris, France

    Background/Purpose: Despite the emergence of new therapies, a considerable proportion of individuals with rheumatoid arthritis (RA) still endure symptoms, giving rise to the concept of…
  • Abstract Number: 0060 • ACR Convergence 2024

    Spectral Cytometry Shows Increased CD56hi NK Cells and New HLA-DR+CD56+ Phenotypes in RA

    Estelle Khairallah1, Haani Qudsi2, Jihad Ben Gabr1, Andras Perl3 and Christian Geier1, 1SUNY Upstate Medical University, Syracuse, NY, 2Norton College of Medicine, Syracuse, NY, 3SUNY, Syracuse, NY

    Background/Purpose: Previous studies of RA patients have shown changes in NK cell populations (as defined by CD56 expression). The nature of these cellular changes remains…
  • Abstract Number: 0147 • ACR Convergence 2024

    Clinical Characteristics and Biomarkers Associated with Detectable High-Sensitivity Cardiac Troponin in Patients with Rheumatoid Arthritis

    Ilana Usiskin1, Mary Jeffway1, Feng Liu1, Nancy Shadick1, Michael Weinblatt2, Brittany Weber3 and Katherine Liao1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital/ Harvard Medical School, Waban, MA, 3Brigham and Women's Hospital, DEDHAM, MA

    Background/Purpose: General population-based cardiovascular (CV) risk estimators are known to underestimate CV risk in RA. High-sensitivity cardiac troponin T (hs-cTnT), typically measured during a work-up…
  • Abstract Number: 0228 • ACR Convergence 2024

    Do Imaging Tests Have a Role in Predicting Progression to Rheumatoid Arthritis in People with Clinically Suspect Arthralgia? A Systematic Review & Meta-Analysis

    Ankita Gupta1, Sulaiman Anis2 and Paola de Pablo2, 1Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom, 2University of Birmingham, Birmingham, United Kingdom

    Background/Purpose: Clinically suspect arthralgia (CSA) has been associated with an increased risk of developing inflammatory arthritis (IA). Subclinical inflammation on imaging tests may help to…
  • Abstract Number: 0419 • ACR Convergence 2024

    Placental Weights of Offspring Born to Women with Rheumatoid Arthritis and Juvenile Idiopathic Arthritis

    Eugenia Chock1, Zeyan Liew2, Lars Henning Pedersen3 and Mette Oestergaard Thunbo3, 1Yale School of Medicine, New Haven, CT, 2Yale Center for Perinatal, Pediatric and Environmental Epidemiology, New Haven, CT, 3Aarhus University, Aarhus, Denmark

    Background/Purpose: Offspring of patients with chronic inflammatory arthritis have almost double the risk of being born small for gestational age. Placental insufficiency is one of…
  • Abstract Number: 0464 • ACR Convergence 2024

    Increases in Paraoxonase-1 Activity over Time Associates with Reduced Risk of Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population

    Amir Razmjou1, Rong Guo2, David Elashoff3, Kevin Deane4, Jill Norris5, Marie Feser6, Jennifer Wang1, Ani Shahbazian2 and christina Charles-Schoeman7, 1UCLA, Los Angeles, CA, 2UCLA, Los Angeles, 3UCLA Department of Medicine Statistics Core, Los Angeles, 4University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 5Colorado School of Public Health, Denver, CO, 6Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 7UCLA Medical Center, Santa Monica, CA

    Background/Purpose: Rheumatoid arthritis (RA) has a well described pre-clinical state, with a continuum of genetic and environmental risk factors leading to the development of systemic…
  • Abstract Number: 0480 • ACR Convergence 2024

    Can’t Sleep, Won’t Sleep: A Systematic Review and Meta-Analysis of Insomnia Prevalence in 70,105 Rheumatoid Arthritis Patients

    Mohamed Abdelsalam1, Mamdouh Ahmed Khairy2, Mohamed Reda Awad3, Aly Alnabawy2, Maryam Taha4 and Mohamed Al-Adl Ali Ali2, 1Rheumatology, Rehabilitation and Physical medicine department - faculty of medicine -Misr University for science and technology, 6th of October, Al Jizah, Egypt, 2Faculty of medicine - Al-Azhar university Cairo branch, Cairo, Egypt, 3Al Azhar University, Cairo, Egypt, Giza, Egypt, 4Faculty of medicine - Ain Shams university, Madinat Nasr, Al Qahirah, Egypt

    Background/Purpose: Insomnia is a significant challenge for rheumatoid arthritis (RA) patients. Chronic pain conditions often exacerbate sleep disturbances, creating a vicious cycle where pain and…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 188
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology